Selective increases in type I hydrogen from reduced nicotinamide-adenine dinucleotide phosphate in liver from phenobarbitone-treated rats.
D000818:Animals; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D006859:Hydrogen / Q000096:biosynthesis*; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D009243:NAD / Q000378:metabolism; D009249:NADP / Q000378:metabolism*; D010084:Oxidation-Reduction; D010634:Phenobarbital / Q000494:pharmacology*; D010734:Phosphogluconate Dehydrogenase / Q000378:metabolism; D051381:Rats
D009243:NAD; D009249:NADP; D006859:Hydrogen; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D010634:Phenobarbital